Reconstitution and dosing guides
Cited, practical walkthroughs of peptide and GLP-1 reconstitution, dosing, and pharmacology. Every guide links to the matching calculator so you can run your own numbers.
47 guides11 compoundsEvery guide cited
Tirzepatide Side Effects (What the FDA Label Lists)
A neutral, label-cited summary of tirzepatide side effects, the common gastrointestinal reactions, the boxed warning on thyroid C-cell tumors, and the warnings.
Semaglutide Side Effects (What the FDA Label Lists)
A neutral, label-cited summary of semaglutide side effects, the common GI reactions, the boxed warning on thyroid C-cell tumors, and the labeled warnings.
Retatrutide Dosage: The Phase 2 Trial Escalation Explained
Retatrutide has no FDA-approved dose. See the weekly escalation used in the NEJM Phase 2 trial, why it steps up, and how to convert a dose to syringe units.
Tirzepatide
5 guidesWhat Is Bacteriostatic Water?
Bacteriostatic water is sterile water with 0.9% benzyl alcohol that lets a reconstituted vial be used more than once. How it differs from sterile water and saline.
Tirzepatide vs Semaglutide: Mechanism, Dosing, and Evidence
A cited comparison of tirzepatide and semaglutide covering receptor mechanism, weekly dosing, approved brands, and the SURPASS-2 head to head trial results.
Tirzepatide Side Effects (What the FDA Label Lists)
A neutral, label-cited summary of tirzepatide side effects, the common gastrointestinal reactions, the boxed warning on thyroid C-cell tumors, and the warnings.
Tirzepatide Dosage Chart and Titration Schedule
A cited tirzepatide dosage chart with the FDA titration schedule, the six approved doses, and how to convert each dose to units on a U-100 insulin syringe.
How to Reconstitute Tirzepatide (Step by Step)
A step by step guide to reconstituting tirzepatide with bacteriostatic water, the concentration math, and how to convert your dose to syringe units.
Semaglutide
6 guidesWhere to Inject Semaglutide (Sites and Timing)
A label-cited guide to semaglutide injection sites (abdomen, thigh, upper arm), site rotation, once-weekly timing, and what the label says about a missed dose.
Semaglutide Side Effects (What the FDA Label Lists)
A neutral, label-cited summary of semaglutide side effects, the common GI reactions, the boxed warning on thyroid C-cell tumors, and the labeled warnings.
Semaglutide Dosage Chart (Ozempic and Wegovy)
A cited semaglutide dosage chart with the FDA Ozempic and Wegovy titration schedules, their maximum doses, and how to convert each dose to syringe units.
Ozempic vs Wegovy (Same Drug, Different Label)
Ozempic and Wegovy are both semaglutide. A cited comparison of their indications, maximum doses, schedules, and side effects, with no recommendation.
How to Reconstitute Semaglutide (Step by Step)
A step by step guide to reconstituting semaglutide with bacteriostatic water, the concentration math, and how to convert your dose to syringe units.
Compounded Semaglutide (What It Is and Its Current Status)
A neutral explainer on compounded semaglutide, what it is, why it became common, and the current FDA status after the 2025 shortage resolution. Not advice.
Orforglipron
4 guidesOrforglipron Weight Loss: What the ATTAIN Phase 3 Trials Showed
What orforglipron (Foundayo) weight loss looks like in the ATTAIN phase 3 trials: how much, over how long, and how the trial doses differ from the label.
Orforglipron vs Zepbound: Daily Pill vs Weekly Shot for Weight Loss
Orforglipron vs Zepbound for weight loss: a cited look at the daily oral GLP-1 pill against the weekly tirzepatide injection, on dosing, trials, and trade-offs.
Orforglipron vs Tirzepatide: Oral Pill vs Injection
A cited comparison of orforglipron (the oral GLP-1 pill) and tirzepatide: mechanism, daily pill vs weekly injection, approved dosing, and trial weight loss.
Orforglipron (Foundayo) Price and Cost: Self-Pay, Insurance, and Savings
Orforglipron (Foundayo) price and cost in 2026: self-pay vs insured, LillyDirect, and the savings card, with figures dated and sourced. Verify current pricing.
Retatrutide
5 guidesRetatrutide vs Tirzepatide: Triple vs Dual Agonist
Retatrutide is an investigational triple GIP/GLP-1/glucagon agonist. Tirzepatide is an FDA-approved dual agonist. A cited mechanism and status comparison.
Retatrutide Side Effects: What the Phase 2 Trial Reported
Retatrutide is investigational, so its side effect data comes from trials, not an FDA label. The Phase 2 trial reported dose-related gastrointestinal events.
Retatrutide Results: What the Phase 2 Trial Reported
In the NEJM Phase 2 trial, retatrutide produced dose-dependent weight reduction up to 24.2% at 48 weeks. These are cited trial averages, not a personal prediction.
Retatrutide Dosage: The Phase 2 Trial Escalation Explained
Retatrutide has no FDA-approved dose. See the weekly escalation used in the NEJM Phase 2 trial, why it steps up, and how to convert a dose to syringe units.
How to Reconstitute Retatrutide (Step by Step)
Reconstitute retatrutide by adding bacteriostatic water to the lyophilized vial. The water volume sets the concentration; the calculator gives your units.
BPC-157
5 guidesHow to Reconstitute BPC-157 (Step by Step)
How to reconstitute BPC-157: add bacteriostatic water to the vial, swirl, do not shake. The water volume sets the concentration, and units equal mL x 100.
BPC-157 Side Effects (What the Limited Human Data Show)
BPC-157 has no FDA-established human safety profile. Human data are very limited and most safety information comes from animal studies. A neutral, cited summary.
BPC-157 Dosage (Why There Is No Established Human Dose)
BPC-157 has no FDA-approved or established human dose. Informal protocols cite 250 to 500 mcg daily, which is not a recommendation. How to convert a dose to units.
BPC-157 Benefits (What Preclinical Research Has Studied)
BPC-157 has been studied in animal and cell research for tissue repair and angiogenesis. These are preclinical findings, not proven human benefits.
BPC-157 and TB-500 (Why the Stack Has No Established Dose)
The BPC-157 and TB-500 stack has no controlled human trial and no evidence-based dose ratio. Researchers calculate each compound separately. Neither is FDA-approved.
Tesamorelin
4 guidesWhat Is Tesamorelin? GHRH Analogue and Egrifta, Explained
Tesamorelin is a GHRH analogue, FDA-approved as Egrifta only for HIV-associated lipodystrophy. What it is, how it works, and what off-label use means.
Tesamorelin vs Sermorelin (and Ipamorelin, CJC-1295)
Tesamorelin vs sermorelin, ipamorelin, and CJC-1295: class, mechanism, approval status, and dosing compared. Only tesamorelin has an FDA indication.
Tesamorelin Side Effects: What the Egrifta Label Lists
What the Egrifta (tesamorelin) FDA label lists as side effects: injection-site reactions, joint pain, glucose and IGF-1 effects, and contraindications.
Tesamorelin Before and After: What the Phase 3 Trials Measured
What tesamorelin's Phase 3 trials measured: visceral fat reduction in HIV lipodystrophy over 26 weeks. Cited trial averages, not a weight-loss promise.
CJC-1295 / Ipamorelin
4 guidesWhat Is CJC-1295 / Ipamorelin? The Peptide Blend Explained
CJC-1295 and Ipamorelin are research peptides (a GHRH analogue plus a selective secretagogue) sold as one blend. What they are and how they work.
CJC-1295 / Ipamorelin Side Effects: What the Research Shows
CJC-1295 / Ipamorelin side effects: what the limited research shows. These are research peptides, not FDA-approved, with limited human safety data.
CJC-1295 / Ipamorelin Benefits: What the Studies Measured
CJC-1295 / Ipamorelin benefits: what the studies measured (GH and IGF-1), and why that is not proof of muscle, fat loss, or anti-aging in humans.
CJC-1295 DAC vs No-DAC (Modified GRF 1-29): The Difference
CJC-1295 with DAC vs without DAC (modified GRF 1-29): the half-life difference, which form is in a blend, and why it matters. Cited and neutral.
Sermorelin
4 guidesWhat Is Sermorelin? GHRH Analogue and Geref, Explained
Sermorelin is a GHRH analogue that prompts the body's own growth hormone. What it is, the Geref history, and how it differs from taking HGH.
Sermorelin Side Effects: What the Geref Label and Class Show
Sermorelin side effects from the Geref label and the GH-secretagogue class: injection-site reactions, fluid effects, and the off-label-use caveat.
Sermorelin Benefits: What the Evidence Actually Shows
Sermorelin benefits: what the GH and IGF-1 evidence and the Geref history actually show, and why the marketed anti-aging claims outrun the evidence.
Sermorelin Before and After: Results and a Realistic Timeline
Sermorelin before and after: what it was studied to do, why transformation content is not trial evidence, and a realistic results timeline.
MOTS-c
4 guidesWhat Is MOTS-c? The Mitochondrial-Derived Peptide Explained
MOTS-c is a mitochondrial-derived research peptide studied for metabolism and insulin sensitivity. What it is, how it works, and why human data are limited.
MOTS-c Side Effects: What the Limited Research Shows
MOTS-c side effects: there is no human safety data and no FDA approval. What the research shows, and why the missing human evidence is the real risk.
MOTS-c Benefits: What the Research Actually Studied
MOTS-c benefits: what the cell and animal research studied (metabolism, insulin sensitivity), and why no human trials establish the marketed claims.
MOTS-c Before and After: What the Evidence Can and Cannot Say
MOTS-c before and after: why there is essentially no human outcome data, why transformation content is not evidence, and what the research studied.
TB-500
4 guidesWhat Is TB-500? The Thymosin Beta-4 Peptide Explained
TB-500 is a synthetic fragment of thymosin beta-4, a research peptide studied for tissue repair. What it is, how it works, and why it is not FDA-approved.
TB-500 vs BPC-157: How the Two Healing Peptides Differ
TB-500 vs BPC-157: how the two research healing peptides differ in origin, mechanism, and evidence. Both are research peptides, not FDA-approved.
TB-500 Side Effects: What the Limited Research Shows
TB-500 side effects: no human safety data, not FDA-approved, and banned in sport. What the research context suggests and what is simply unknown.
TB-500 Benefits: What the Research Actually Studied
TB-500 benefits: what the cell and animal research on thymosin beta-4 studied (wound healing, tissue repair), and why human outcome data are absent.
cagrilintide
2 guidesCagrilintide Side Effects: What the Phase 2 Trial Reported
Cagrilintide is investigational with no FDA label. See the gastrointestinal side effects reported in the Lancet phase 2 trial and what long-term data is missing.
Cagrilintide Dosage: What the Phase 2 Trial Used
Cagrilintide has no FDA-approved dose. See the once-weekly range from the Lancet phase 2 trial, the CagriSema pairing, and how to convert a dose to units.